Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Yunnan Baiyao Group Co Ltd

000538.SZ ✓ COMPLIANT ☆ Track — members

SZSE · Healthcare · Pharmaceuticals ·

China Large Cap Analyst: BUY

Last Close

$7.42

▼ -0.85%

Market Cap $13.24B · Vol 7.93M

Key Metrics

P/E Ratio

16.98

FWD: 14.93

Market Cap

$13.24B

Large Cap

Div Yield

5.20%

Semi-annual dividend

EPS Growth

+12.03%

YoY

RSI (14)

40.22

Momentum

Beta

0.28

vs Market

52W High

$9.00

12.91% below

52W Low

$6.87

8.92% above

Volume

7.93M

Avg 11.53M

P/B

2.51

Price-to-book

ROE

12.97%

Return on equity

Free Float

39.09%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Yunnan Baiyao Group Co Ltd (000538.SZ) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 000538.SZ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.44%

-0.04%

-2.85%

-11.45%

YTD

-11.86%

-10.47%

+0.24%

-25.91%

Financials & Valuation

TTM · Annual

Total Revenue	$5.89B
Net Income	$742.15M
Revenue Growth (YoY)	+1.81%
Gross Margin	28.90%
Operating Margin	11.74%
Net Profit Margin	12.60%
ROE	12.97%
ROA · ROIC	11.28% · 12.60%

P/E Ratio	16.98
Forward P/E (FY1)	14.93
PEG Ratio	2.31
P/S	2.46
P/B	2.51
P/FCF	24.58
EPS Growth	+12.03%
Outstanding Shares	1.78B

Technical Indicators

50-Day SMA	$7.42
200-Day SMA	$8.01
RSI (14)	40.22
Beta	0.28
52-Week High	$9.00
52-Week Low	$6.87

Volume Today	7.93M
Avg Daily Volume (30D)	11.53M
Relative Volume	0.69x
Volatility (10D)	10.41
Volatility (30D)	17.40
Free Float	39.09%

Analyst Consensus

BUY

Current Price $7.42

Mean Target $10.31

52W Low$6.87 52W High$9.00

Current

Target

$6.87 $9.00

Current Analyst target

+38.91% upside potential · 10 analysts

Identifiers

ExchangeSZSE

FIGIBBG001SJWS71

ISINCNE0000008X7

CountryChina

Sub-IndustryAlternative Medicine

Earnings DateAug 29, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

600085.SS Beijing Tong Ren Tang Co Ltd -1.45% 000423.SZ Dong-E-E-Jiao Co Ltd -1.44% 002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd -0.82% 600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd -1.69% 600535.SS Tasly Pharmaceutical Group Co Ltd -0.65%

Company Profile

Yunnan Baiyao Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of traditional Chinese medicine (TCM) products. The Company mainly operates four businesses. The pharmaceutical business is primarily engaged in the research, development and production of Yunnan Baiyao series products, including Yunnan Baiyao Aerosol, Yunnan Baiyao Plaster and Yunnan Baiyao Woundplast, as well as Panax notoginseng-based botanical supplements. The health products business is primarily engaged in the production and sales of toothpaste category, oral care and Yangyuanqing anti-hair loss solutions. The TCM resources business is primarily engaged in the building of digital management and operation ecosystem for the entire industrial chain of Chinese medicinal materials. The Yunnan pharma business is mainly engaged in the wholesale and retail of pharmaceuticals. The Company mainly operates its businesses in the domestic market.